These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19262544)

  • 21. The appropriate use of proton-pump inhibitors.
    Savarino V; Marabotto E; Zentilin P; Furnari M; Bodini G; De Maria C; Pellegatta G; Coppo C; Savarino E
    Minerva Med; 2018 Oct; 109(5):386-399. PubMed ID: 29856192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD).
    Pohle T; Domschke W
    Langenbecks Arch Surg; 2000 Aug; 385(5):317-23. PubMed ID: 11026702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
    ; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
    JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marked increase in proton pump inhibitors use in Australia.
    Hollingworth S; Duncan EL; Martin JH
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review article: treatment of mild and severe cases of GERD.
    Tytgat GN
    Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():73-8. PubMed ID: 12047264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
    Moayyedi P
    Digestion; 2008; 78 Suppl 1():61-9. PubMed ID: 18832842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
    Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
    Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
    Hong MT; Monye LC; Seifert CF
    Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors (PPIs) may cause gastric cancer - clinical consequences.
    Waldum HL; Sørdal Ø; Fossmark R
    Scand J Gastroenterol; 2018 Jun; 53(6):639-642. PubMed ID: 29852782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors in the management of gastroesophageal reflux disease.
    Hrelja N; Zerem E
    Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitor prescribing and costs in a large outpatient clinic.
    Hood W; McJunkin B; Warnock A; Girme A; Smith N; Robinson B
    W V Med J; 2014; 110(1):16-21. PubMed ID: 24640269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):9-16. PubMed ID: 29309399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.